Life Sciences
Findings from Washington University advance knowledge in life sciences
Published in Cancer Weekly, June 23rd, 2009
"Repeat right lobar radioembolization with supratherapeutic activity of (90)y caused shrinking of the tumors and the right lobe with no adverse outcome. With an adequate tumor-free future liver remnant, one hepatic lobe bearing a large tumor burden may be administered supratherapeutic activity of Y-90, risking lobar ablation for greater probability of tumor eradication. This is analogous to...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2009-06-23)
More Articles from Cancer Weekly
- Cancer Gene Therapy
Findings in cancer gene therapy reported from University of Pennsylvania, Medical Department - Cancer Gene Therapy
New cancer gene therapy research from A. Azatian and colleagues discussed - Cancer Gene Therapy
Report summarizes cancer gene therapy study findings from Hokkaido University, Medical Department - Cancer Gene Therapy
Research on cancer gene therapy reported by E. Kuwada et al - Cancer Vaccines
Data on cancer vaccines published by researchers at National Cancer Institute - Cancer Vaccines
New cancer vaccines study findings recently were published by researchers at University of California - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
